Bank Hapoalim BM Sells 200 Shares of Intuitive Surgical, Inc. (NASDAQ:ISRG)

Bank Hapoalim BM cut its position in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 23.6% in the 3rd quarter, Holdings Channel.com reports. The firm owned 647 shares of the medical equipment provider’s stock after selling 200 shares during the period. Bank Hapoalim BM’s holdings in Intuitive Surgical were worth $318,000 at the end of the most recent quarter.

Several other large investors have also recently bought and sold shares of the company. Ullmann Wealth Partners Group LLC lifted its stake in shares of Intuitive Surgical by 1.6% in the 3rd quarter. Ullmann Wealth Partners Group LLC now owns 1,329 shares of the medical equipment provider’s stock valued at $653,000 after acquiring an additional 21 shares during the last quarter. One Wealth Management Investment & Advisory Services LLC lifted its stake in shares of Intuitive Surgical by 3.4% in the 2nd quarter. One Wealth Management Investment & Advisory Services LLC now owns 697 shares of the medical equipment provider’s stock valued at $310,000 after acquiring an additional 23 shares during the last quarter. Daymark Wealth Partners LLC lifted its stake in shares of Intuitive Surgical by 0.3% in the 3rd quarter. Daymark Wealth Partners LLC now owns 7,027 shares of the medical equipment provider’s stock valued at $3,452,000 after acquiring an additional 24 shares during the last quarter. Indiana Trust & Investment Management CO lifted its stake in shares of Intuitive Surgical by 5.3% in the 2nd quarter. Indiana Trust & Investment Management CO now owns 500 shares of the medical equipment provider’s stock valued at $222,000 after acquiring an additional 25 shares during the last quarter. Finally, Hoxton Planning & Management LLC lifted its stake in shares of Intuitive Surgical by 4.9% in the 2nd quarter. Hoxton Planning & Management LLC now owns 534 shares of the medical equipment provider’s stock valued at $238,000 after acquiring an additional 25 shares during the last quarter. 83.64% of the stock is currently owned by institutional investors.

Intuitive Surgical Stock Performance

Intuitive Surgical stock traded down $3.36 during mid-day trading on Thursday, reaching $510.41. 29,517 shares of the company were exchanged, compared to its average volume of 1,456,077. The business has a fifty day moving average of $489.74 and a 200 day moving average of $445.30. The firm has a market cap of $181.80 billion, a P/E ratio of 82.60, a PEG ratio of 5.11 and a beta of 1.39. Intuitive Surgical, Inc. has a 12-month low of $260.17 and a 12-month high of $523.34.

Insider Transactions at Intuitive Surgical

In other news, EVP Robert Desantis sold 240 shares of the company’s stock in a transaction on Monday, August 12th. The stock was sold at an average price of $464.76, for a total transaction of $111,542.40. Following the transaction, the executive vice president now directly owns 5,506 shares of the company’s stock, valued at approximately $2,558,968.56. This represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. In other Intuitive Surgical news, insider Mark Brosius sold 2,115 shares of the stock in a transaction dated Thursday, September 12th. The stock was sold at an average price of $491.91, for a total transaction of $1,040,389.65. Following the sale, the insider now directly owns 295 shares of the company’s stock, valued at approximately $145,113.45. This trade represents a 0.00 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, EVP Robert Desantis sold 240 shares of the stock in a transaction dated Monday, August 12th. The stock was sold at an average price of $464.76, for a total value of $111,542.40. Following the sale, the executive vice president now directly owns 5,506 shares in the company, valued at $2,558,968.56. This represents a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last three months, insiders have sold 50,095 shares of company stock valued at $24,552,712. Corporate insiders own 0.80% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of equities research analysts have recently weighed in on ISRG shares. Leerink Partners boosted their target price on Intuitive Surgical from $489.00 to $502.00 in a research note on Thursday, October 17th. Truist Financial boosted their target price on Intuitive Surgical from $520.00 to $570.00 and gave the company a “buy” rating in a research note on Monday, October 14th. Wells Fargo & Company boosted their target price on Intuitive Surgical from $466.00 to $549.00 and gave the company an “overweight” rating in a research note on Friday, October 18th. Redburn Atlantic upgraded Intuitive Surgical from a “neutral” rating to a “buy” rating and increased their price objective for the stock from $380.00 to $510.00 in a report on Friday, August 2nd. Finally, Royal Bank of Canada increased their price objective on Intuitive Surgical from $525.00 to $555.00 and gave the stock an “outperform” rating in a report on Friday, October 18th. One equities research analyst has rated the stock with a sell rating, five have issued a hold rating and fourteen have assigned a buy rating to the company’s stock. According to data from MarketBeat, Intuitive Surgical currently has a consensus rating of “Moderate Buy” and an average target price of $513.74.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.